Oculis Holding AG (CR5) Stock Price & News

All values in CHF	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	243,00 k	411,00 k	209,00 k	310,00 k
Cost of goods sold	14,12 m	13,29 m	14,05 m	15,28 m
Cost of revenue	14,12 m	13,29 m	14,05 m	15,28 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6,42 m	7,76 m	7,89 m	8,60 m
Operating expense	6,42 m	7,76 m	7,89 m	8,60 m
Total operating expenses	20,54 m	21,04 m	21,94 m	23,88 m
Operating income	-20,30 m	-20,63 m	-21,73 m	-23,57 m
Other non operating income	3,09 m	-3,24 m	-7,98 m	12,10 m
EBT including unusual items	-16,84 m	-23,70 m	-28,95 m	-9,96 m
EBT excluding unusual items	-16,84 m	-23,70 m	-28,95 m	-9,96 m
Income tax expense	13,00 k	-182,00 k	-98,00 k	6,00 k
Effective tax rate	-0,08%	0,77%	0,34%	-0,06%
Other operating expenses	-	-	-	-
Net income	-16,86 m	-23,51 m	-28,85 m	-9,97 m
Net profit margin	-6 936,21%	-5 721,17%	-13 804,78%	-3 216,13%
Earnings per share	-0,32	-0,42	-0,49	-0,16
Interest and investment income	438,00 k	319,00 k	367,00 k	592,00 k
Interest expense	-162,00 k	-241,00 k	-173,00 k	-309,00 k
Net interest expenses	276,00 k	78,00 k	194,00 k	283,00 k
Depreciation and amortization charges	-	-	-	-
EBITDA	-20,14 m	-20,60 m	-21,57 m	-23,39 m
Gain or loss from assets sale	-	-	-	-

Finance